BioNTech SE (BNTX) Return on Invested Capital (2019 - 2025)
BioNTech SE (BNTX) reported Return on Invested Capital of 0.53% for Q3 2025, down 40.0% on a YoY basis from 0.88% in Q3 2024, and up 13.53% sequentially from 0.61% in Q2 2025.
BioNTech SE (BNTX) Return on Invested Capital (2019 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 7 years of Return on Invested Capital data on file, last reported at 0.53% in Q3 2025.
- For the quarter ending Q3 2025, Return on Invested Capital fell 40.0% year-over-year to 0.53%; the trailing twelve-month figure through Sep 2025 stood at 0.53% (down 40.0% YoY), and the FY2024 full-year result was 0.48%, down 86.0% from the prior year.
- Return on Invested Capital climbed to 0.53% in Q3 2025, from 0.61% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 6.0% in Q1 2023 to a low of 0.85% in Q1 2025.
- A 5-year average of 0.42% and a median of 0.14% in 2023 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital soared 585 bps in 2023 and slumped 611 bps in 2024, its largest moves.
- Tracing BNTX's Return on Invested Capital over 5 years: stood at 0.21% in 2021, then rose by 11 bps to 0.24% in 2022, then slumped by 41 bps to 0.14% in 2023, then sank by 452 bps to 0.49% in 2024, then decreased by 8 bps to 0.53% in 2025.
- Business Quant data shows BNTX's Return on Invested Capital at 0.53% in Q3 2025, 0.61% in Q2 2025, and 0.85% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.53% |
| Jun 30, 2025 | -0.61% |
| Mar 31, 2025 | -0.85% |
| Dec 31, 2024 | -0.49% |
| Sep 30, 2024 | -0.13% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | 0.14% |
| Sep 30, 2023 | 0.95% |
| Jun 30, 2023 | 1.81% |
| Mar 31, 2023 | 6.00% |
| Dec 31, 2022 | 0.24% |
| Sep 30, 2022 | 0.13% |
| Jun 30, 2022 | 0.15% |
| Mar 31, 2022 | 0.15% |
| Dec 31, 2021 | 0.21% |
| Sep 30, 2021 | 0.52% |
| Jun 30, 2021 | 0.30% |
| Mar 31, 2021 | 0.10% |
| Dec 31, 2020 | 0.03% |